CN117457220B - Informationized management method and system for neurological stroke patients - Google Patents
Informationized management method and system for neurological stroke patients Download PDFInfo
- Publication number
- CN117457220B CN117457220B CN202311805779.XA CN202311805779A CN117457220B CN 117457220 B CN117457220 B CN 117457220B CN 202311805779 A CN202311805779 A CN 202311805779A CN 117457220 B CN117457220 B CN 117457220B
- Authority
- CN
- China
- Prior art keywords
- stroke
- risk
- patient
- index
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000006011 Stroke Diseases 0.000 title claims abstract description 149
- 230000000926 neurological effect Effects 0.000 title claims abstract description 33
- 238000007726 management method Methods 0.000 title claims abstract description 16
- 238000012502 risk assessment Methods 0.000 claims abstract description 48
- 208000024891 symptom Diseases 0.000 claims abstract description 39
- 238000011156 evaluation Methods 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 208000032382 Ischaemic stroke Diseases 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 16
- 238000004364 calculation method Methods 0.000 claims description 14
- 230000002008 hemorrhagic effect Effects 0.000 claims description 12
- 238000010606 normalization Methods 0.000 claims description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 5
- 206010020772 Hypertension Diseases 0.000 claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 201000001421 hyperglycemia Diseases 0.000 claims description 5
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 description 20
- 206010008190 Cerebrovascular accident Diseases 0.000 description 12
- 208000007536 Thrombosis Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 231100000862 numbness Toxicity 0.000 description 8
- 208000019505 Deglutition disease Diseases 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 208000027765 speech disease Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 208000004044 Hypesthesia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 231100000861 limb weakness Toxicity 0.000 description 3
- 208000027905 limb weakness Diseases 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 231100000216 vascular lesion Toxicity 0.000 description 3
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 208000003164 Diplopia Diseases 0.000 description 2
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 206010053649 Vascular rupture Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047555 Visual field defect Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000005978 brain dysfunction Effects 0.000 description 2
- 238000002585 cerebral angiography Methods 0.000 description 2
- 208000013159 conscious disturbance Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000029444 double vision Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 208000018316 severe headache Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 201000007272 intracranial sinus thrombosis Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses an informatization management method and system for a neurological stroke patient, which relate to the technical field of neurological stroke and comprise the following steps: searching and obtaining the past basic medical history, past stroke medical history, family stroke medical history, age and sex of the patient in the medical system, and calculating and obtaining the past evaluation risk indexGpThe method comprises the steps of carrying out a first treatment on the surface of the Obtaining clinical symptoms of the patient, and calculating to obtain clinical risk assessment indexLpThe method comprises the steps of carrying out a first treatment on the surface of the Obtaining a patient's past evaluation risk index Gp i And clinical risk assessment index Lp i Calculating to obtain stroke risk index of patient in neurologyFxThe method comprises the steps of carrying out a first treatment on the surface of the Obtaining a neurological stroke risk index for a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzAnd determining whether further checking is required. The method is beneficial to reducing unnecessary examination and improving the validity of the examination, and medical resources are distributed more reasonably.
Description
Technical Field
The invention relates to the technical field of neurologic stroke, in particular to an informationized management method and system for a neurologic stroke patient.
Background
Neurological stroke refers to a clinical syndrome of acute, focal neurological deficit caused by a central nervous system vascular injury. Such conditions are often caused by cerebrovascular diseases, including cerebral hemorrhage, cerebral thrombosis, cerebral embolism, and the like. In neurology, stroke is a common disease that is often manifested as sudden neurological symptoms such as hemiplegia, aphasia, vision impairment, etc. These symptoms are typically caused by blockage or rupture of cerebral blood vessels, resulting in a decrease or cessation of cerebral blood flow, thereby ischemia hypoxia or necrosis of brain cells. Diagnosis and treatment of neurological stroke requires a combination of patient history, physical examination and imaging examination. The doctor can determine the type and degree of the stroke according to the symptoms and signs of the patient and combining the imaging examination result, and the corresponding treatment scheme is formulated.
In the Chinese application with the application publication number of CN116825368A, a system and a method for informationized management and analysis of stroke patients are disclosed, wherein the system comprises a mobile terminal, a front-end data generation platform and a back-end data summarization platform; the mobile terminal performs data transmission through a wireless communication technology to generate the front-end data generation platform; the back-end data summarizing platform is used for summarizing the data generated by the front-end data platform and feeding back the result to the mobile terminal corresponding to the front-end data generating platform; the mobile terminal comprises a patient end, a community doctor end and a neurology doctor end.
In the application of the invention, a patient can send inquiry information through the app and timely call communities and neurologists when the patient breaks down, so that the rapid diagnosis of the green channel of the apoplexy is realized, precious treatment time is striven for the patient, but in actual use, the expected effect cannot be achieved due to shortage of medical resources, and the conditions of messy calling and medical resource waste occur. Particularly, some patients have light symptoms, but do a large number of unnecessary inquiry and examination, and some patients have serious symptoms, but can not be diagnosed and treated in time because of long-time queuing, so that the patients are life-threatening.
Therefore, the invention provides an informationized management method and system for a neurological stroke patient.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an informationized management method and system for a neurological stroke patient, and the invention calculates and obtains a neurological stroke risk index Fx by acquiring and analyzing the past medical history and temporary symptoms of the patient, provides a comprehensive stroke risk assessment result, more comprehensively knows the stroke risk of the patient and is based on the neurological stroke risk indexFxAnd risk thresholdYzWhether further examination is needed or not is judged, unnecessary examination is reduced, the examination effectiveness is improved, unnecessary examination on low-risk patients is avoided, medical resources are distributed more reasonably, and therefore the technical problems recorded in the background technology are solved.
In order to achieve the above purpose, the invention is realized by the following technical scheme: an informationized management method for a neurological stroke patient comprises the following steps:
in medical treatmentSearching in the system to obtain the past basic medical history, past apoplexy medical history, family apoplexy medical history, age and sex of the patient, and obtaining basic disease coefficient after arrangementJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXbAnd further calculate to obtain the past estimated risk indexGp；
Obtaining clinical symptoms of patients, and obtaining the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp；
Obtaining a past assessment risk index for a patientAnd clinical risk assessment index->Calculating to obtain stroke risk index of patient in neurologyFx；
Obtaining a neurological stroke risk index for a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzAnd determining whether further checking is required.
Further, the medical system is searched for the past basic medical history of the patient, wherein the basic medical history comprises hypertension, hyperglycemia, hyperlipidemia and diabetes, and the number of the basic diseases is recorded as the basic disease coefficientJc；
Hypertension can cause increased pressure on the walls of cerebral blood vessels, thinning the walls of blood vessels, and easily causing rupture or blockage, thereby causing stroke in neurology. Hyperglycemia can cause the increase of blood viscosity, so that the blood flow is unsmooth, thrombus is easy to form, and accordingly, the stroke of neurology is initiated. Hyperlipidemia causes an increase in fat content in blood, which makes the blood become viscous and easy to form thrombus, thereby causing stroke in neurology. Diabetes can lead to vascular lesions and increased blood viscosity, while also increasing the risk of thrombosis, thereby increasing the risk of stroke in neurology.
Searching and acquiring family stroke medical history of patients in medical system, and recording the number of patients suffering from neurologic stroke in family as family coefficientJz；
Cerebral apoplexy has a certain genetic tendency, but is not a direct genetic disease, and people with family medical history of cerebral apoplexy are easier to get cerebral apoplexy than people without family medical history.
Searching and obtaining past stroke medical history of patients in a medical system, wherein the past stroke medical history comprises neurologic stroke, type and time of each neurologic stroke, and obtaining the times of ischemic stroke after finishingQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc。
A great feature of the neurological stroke is high recurrence rate, and the problem is difficult to solve fundamentally due to the pathological change basis of the blood vessel and the existence of dangerous factors, and the illness state is more dangerous and the patient is further away from death after recurrence.
Neurological stroke includes ischemic stroke, also known as cerebral infarction, which is a major type of cerebral stroke, accounting for more than 80% of the total number of cerebral functional disorders due to atherosclerotic plaques in the intima of the cerebral vessels, or blockage of cerebral vessels by thrombosis, emboli, etc. Hemorrhagic stroke is also called cerebral hemorrhage, which is a brain dysfunction caused by cerebral vascular rupture, and is not as common as ischemic stroke, but is critical and has high death rate.
Further, retrieving the age of the patient in the medical systemNlAnd sexXbCombining basic disease coefficientsJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTcFamily coefficientJzAfter dimensionless treatment, calculating to obtain the past estimated risk indexGpCorresponding past evaluation risk indexGpThe calculation formula of (2) is as follows:
；
wherein, if the sex is male, the sex isXbMarking as 1, otherwise if the sex is female, the sexXbAnd is noted as 0.
With increasing age, both the incidence and mortality of stroke have increased significantly, particularly in age groups over 75 years old, with 1.4 to 1.6 times the incidence in the 65-74 year old group, 3-4 times the incidence in the 55-64 year old group, and 5-8 times the incidence in the 45-54 year old group, thus age is one of the important risk factors for stroke occurrence. And the probability of stroke in men is higher than in women, especially after 55 years of age, the risk of stroke in men is higher.
Further, clinical symptoms of the patient are obtained, and the symptoms include headache, dizziness, unbalance, vision problem, speech disorder, limb weakness or numbness, dysphagia and consciousness disturbance from light to heavy; wherein headache and dizziness are classified into mild symptoms, vision problems, speech disorders, limb weakness or numbness, dysphagia are classified into moderate symptoms, conscious disturbance is a severe symptom, and clinical mild symptoms are obtained after arrangementQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZg。
Mild or severe headache is sometimes accompanied by nausea and vomiting. Dizziness refers to feeling to rotate in the sky or itself. Unbalance refers to unstable walking, and easy falling or losing balance. Vision problems are indicative of blurred vision, double vision, or visual field defects. Speech disorders refer to the difficulty in expressing their own ideas, or understanding the speech of others. Weakness or numbness of the limbs refers to the feeling of weakness or numbness of one side limb, which may be a precursor to hemiplegia. Dysphagia refers to the condition of difficulty in swallowing or choking of drinking water. The disturbance of consciousness refers to coma or confusion.
Further, the number of clinical mild symptoms is obtainedQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZg，After linear normalization treatment, calculating to obtain clinical risk assessment indexLp：
；
Corresponding clinical risk assessment indexLpThe calculation formula of (2) is as above.
Further, all the past evaluation risk indexes are obtainedAnd clinical risk assessment index->After dimensionless treatment, calculating to obtain the past estimated risk index ++>Weight of +.>And clinical risk assessment index->Weight of +.>Corresponding anamnesis risk index->Weight of +.>And clinical risk assessment index->Weight of +.>The calculation formula of (2) is as follows:
；
wherein,irepresenting each past evaluation risk indexAnd clinical risk assessment index->Is provided with a sequence number of (c) in the order,and (2) andnis a positive integer.
Further, a past evaluation risk index of the patient is obtainedClinical risk assessment index->Weight->Calculating to obtain stroke risk index of patient in neurologyFx：
；
Corresponding patient neurological stroke risk indexFxThe calculation formula of (2) is as above.
Further, obtaining the neurological stroke risk index of all patientsAfter linear normalization processing, calculating to obtain a risk threshold valueYz：
；
Corresponding risk thresholdYzThe calculation formula of (2) is as above.
Further, obtaining a neurological stroke risk index of the patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzWhether further examination is needed or not is judged, specifically:
when (when)Fx<YzFeedback of the nerve of the current patientThe risk of internal medicine apoplexy is low, the symptoms are light, no further examination is needed, and monitoring is kept continuously so as to prevent abnormal situations;
when (when)Fx≥YzIn the case of a current patient, the risk of stroke in neurology is high, the symptoms are serious, and further examination is needed to determine a specific focus.
An informationized management system for a neurological stroke patient, comprising:
the past risk assessment module is used for searching and acquiring the past basic medical history, past stroke medical history, family stroke medical history, age and sex of a patient in a medical system and acquiring basic disease coefficients after arrangementJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXbAnd further calculate to obtain the past estimated risk indexGp；
The clinical risk assessment module acquires clinical symptoms of patients and obtains the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp；
Comprehensive stroke risk assessment module for obtaining past assessment risk index of patientAnd clinical risk assessment indexCalculating to obtain stroke risk index of patient in neurologyFx；
The checking and judging module is used for acquiring a stroke risk index of a neurology department of a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzAnd determining whether further checking is required.
The invention provides an informatization management method and system for a neurological stroke patient, and the informatization management method and system have the following beneficial effects:
1. the complex past information of the patient is dataized by searching and acquiring the past basic medical history, the past stroke medical history, the family stroke medical history, the age and the sex of the patient in the medical system, so that the data is more visual, easy to understand and convenient to use and analyze, and the time and the energy required for reading and understanding are reduced.
2. The past evaluation risk index is calculated and obtained by analyzing and quantifying the information such as the past basic medical history, the stroke medical history, the family medical history, the age, the sex and the like of the patientGp，A more comprehensive assessment of the patient can be made, helping to understand the overall health and potential risk of the patient.
3. Obtaining clinical symptoms of patients, and obtaining the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp，The patient's illness state can be more comprehensively known, the patient's illness state severity can be more accurately assessed in help, and the basis is provided for making the response scheme.
4. By acquiring past risk assessment indexes and clinical risk assessment indexes, the risk of stroke of the patient is more comprehensively known. The calculation of the stroke risk index Fx in neurology combines the past medical history, clinical symptoms and risk assessment indexes of the patient, provides a comprehensive stroke risk assessment result, and provides scientific basis for whether further examination is needed in the follow-up process.
5. Obtaining a neurological stroke risk index for a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzIs helpful for reducing unnecessary examination, improving the effectiveness of examination, avoiding unnecessary examination of patients with low risk, more reasonably distributing medical resources, and using more resources for other patients with more needs.
Drawings
FIG. 1 is a flow chart of a method for informationized management of stroke patients in neurology according to the present invention;
fig. 2 is a schematic structural diagram of an informationized management system for stroke patients in neurology according to the present invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Referring to fig. 1, the invention provides a method and a system for informationized management of a neurological stroke patient, comprising the following steps:
step one, searching and obtaining the past basic medical history, past stroke medical history, family stroke medical history, age and sex of a patient in a medical system, and obtaining basic disease coefficients after finishingJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXbAnd further calculate to obtain the past estimated risk indexGp。
The first step comprises the following steps:
step 101, searching and obtaining the prior basic medical history of the patient in the medical system, wherein the basic medical history comprises hypertension, hyperglycemia, hyperlipidemia and diabetes, and recording the number of the basic diseases as basic disease coefficientsJc。
Hypertension can cause increased pressure on the walls of cerebral blood vessels, thinning the walls of blood vessels, and easily causing rupture or blockage, thereby causing stroke in neurology. Hyperglycemia can cause the increase of blood viscosity, so that the blood flow is unsmooth, thrombus is easy to form, and accordingly, the stroke of neurology is initiated. Hyperlipidemia causes an increase in fat content in blood, which makes the blood become viscous and easy to form thrombus, thereby causing stroke in neurology. Diabetes can lead to vascular lesions and increased blood viscosity, while also increasing the risk of thrombosis, thereby increasing the risk of stroke in neurology.
Step 102, searching and obtaining the past stroke history of the patient in the medical systemThe history of stroke includes, neurological stroke, type and time of each neurological stroke, and number of ischemic strokes obtained after finishingQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc。
A great feature of the neurological stroke is high recurrence rate, and the problem is difficult to solve fundamentally due to the pathological change basis of the blood vessel and the existence of dangerous factors, and the illness state is more dangerous and the patient is further away from death after recurrence.
Neurological stroke includes ischemic stroke, also known as cerebral infarction, which is a major type of cerebral stroke, accounting for more than 80% of the total number of cerebral functional disorders due to atherosclerotic plaques in the intima of the cerebral vessels, or blockage of cerebral vessels by thrombosis, emboli, etc. Hemorrhagic stroke is also called cerebral hemorrhage, which is a brain dysfunction caused by cerebral vascular rupture, and is not as common as ischemic stroke, but is critical and has high death rate.
Step 103, searching and obtaining family stroke medical history of the patient in the medical system, and recording the number of people suffering from the neurological stroke in the family as a family coefficientJz。
Cerebral apoplexy has a certain genetic tendency, but is not a direct genetic disease, and people with family medical history of cerebral apoplexy are easier to get cerebral apoplexy than people without family medical history.
Step 104, retrieving and obtaining the age of the patient in the medical systemNlAnd sexXbCombining basic disease coefficientsJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTcFamily coefficientJzAfter dimensionless treatment, calculating to obtain the past estimated risk indexGpCorresponding past evaluation risk indexGpThe calculation formula of (2) is as follows:
；
wherein, if there is sexSex in menXbMarking as 1, otherwise if the sex is female, the sexXbAnd is noted as 0.
With increasing age, both the incidence and mortality of stroke have increased significantly, particularly in age groups over 75 years old, with 1.4 to 1.6 times the incidence in the 65-74 year old group, 3-4 times the incidence in the 55-64 year old group, and 5-8 times the incidence in the 45-54 year old group, thus age is one of the important risk factors for stroke occurrence. And the probability of stroke in men is higher than in women, especially after 55 years of age, the risk of stroke in men is higher.
In use, the contents of steps 101 to 104 are combined:
the basic disease coefficient is obtained after the medical system is searched and obtainedJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXb，The complex patient past information is dataized, so that the data is more visual, easier to understand and more convenient to use and analyze, and the time and effort required for reading and understanding are reduced.
The past evaluation risk index is calculated and obtained by analyzing and quantifying the information such as the past basic medical history, the stroke medical history, the family medical history, the age, the sex and the like of the patientGp，A more comprehensive assessment of the patient can be made, helping to understand the overall health and potential risk of the patient.
Step two, obtaining clinical symptoms of the patient, and obtaining the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp。
The second step comprises the following steps:
step 201, obtaining clinical symptoms of a patient, wherein the symptoms include headache, dizziness, unbalance, vision problem, speech disorder, limb weakness or numbness, dysphagia and consciousness disturbance from light to heavy. Wherein headache and dizziness are classified as mild symptomsVision problems, speech disorders, weakness or numbness of the limbs, dysphagia are classified as moderate symptoms, and conscious disturbance as severe symptoms. The number of clinical mild symptoms is obtained after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZg。
Mild or severe headache is sometimes accompanied by nausea and vomiting. Dizziness refers to feeling to rotate in the sky or itself. Unbalance refers to unstable walking, and easy falling or losing balance. Vision problems are indicative of blurred vision, double vision, or visual field defects. Speech disorders refer to the difficulty in expressing their own ideas, or understanding the speech of others. Weakness or numbness of the limbs refers to the feeling of weakness or numbness of one side limb, which may be a precursor to hemiplegia. Dysphagia refers to the condition of difficulty in swallowing or choking of drinking water. The disturbance of consciousness refers to coma or confusion.
Step 202, obtaining the number of clinical mild symptomsQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZg，After linear normalization treatment, calculating to obtain clinical risk assessment indexLp：
；
Corresponding clinical risk assessment indexLpThe calculation formula of (2) is as above.
In use, the contents of steps 201 and 202 are combined:
obtaining clinical symptoms of patients, and obtaining the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp，The patient's illness state can be more comprehensively known, the patient's illness state severity can be more accurately assessed in help, and the basis is provided for making the response scheme.
Step three, acquiring a past evaluation risk index of the patientAnd clinical risk assessment index->Calculating to obtain stroke risk index of patient in neurologyFx。
The third step comprises the following steps:
step 301, obtaining all past evaluation risk indexesAnd clinical risk assessment index->After dimensionless treatment, calculating to obtain the past estimated risk index ++>Weight of +.>And clinical risk assessment index->Weight of +.>Corresponding anamnesis risk index->Weight of +.>And clinical risk assessment index->Weight of +.>The calculation formula of (2) is as follows:
；
wherein,irepresenting each past evaluation risk indexAnd clinical risk assessment index->Is provided with a sequence number of (c) in the order,and (2) andnis a positive integer.
Step 302, obtaining a past evaluation risk index of the patientClinical risk assessment index->Weight->Calculating to obtain stroke risk index of patient in neurologyFx：
；
Corresponding patient neurological stroke risk indexFxThe calculation formula of (2) is as above.
In use, the contents of steps 301 and 302 are combined:
by acquiring the past risk assessment index and the clinical risk assessment index, the risk of stroke of the patient can be more comprehensively known. The calculation of the stroke risk index Fx in neurology combines the past medical history, clinical symptoms and risk assessment indexes of the patient, provides a comprehensive stroke risk assessment result, and provides scientific basis for whether further examination is needed in the follow-up process.
Step four, acquiring a stroke risk index of the neurology of the patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzAnd determining whether further checking is required.
The fourth step comprises the following steps:
step 401, acquiring nerves of all patientsRisk index for medical strokeAfter linear normalization processing, calculating to obtain a risk threshold valueYz：
；
Corresponding risk thresholdYzThe calculation formula of (2) is as above.
Step 402, obtaining a neurological stroke risk index of the patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzWhether further examination is needed or not is judged, specifically:
when (when)Fx<YzWhen the method is used, the risk of stroke in the neurology of the current patient is low, the symptoms are light, further examination is not needed, and monitoring is kept continuously so as to prevent abnormal conditions.
When (when)Fx≥YzAt the time, the current patient is fed back that the stroke risk of the neurology is high, the symptoms are serious, and further examination including craniocerebral CT, craniocerebral Magnetic Resonance Imaging (MRI) and cerebral angiography (DSA) is needed to determine specific focus.
Craniocerebral CT can accurately identify most cerebral strokes and help identify non-vascular lesions.
Craniocerebral Magnetic Resonance Imaging (MRI) is most sensitive to acute cerebral infarction, with a significantly high signal, dispersion Weighted Imaging (DWI). MRI can also be used for vascular imaging, and lesions of cerebral apoplexy caused by aneurysms, venous sinus thrombosis and the like are shown.
Cerebral angiography (DSA) is a invasive examination that requires hospitalization followed by local anesthesia in the operating room. The device can clearly display the branches of each level of cerebral blood vessels and the positions, the sizes, the forms and the distribution of cerebral apoplexy, understand the change of blood flow dynamics, and provide reliable etiology and pathological anatomy for endovascular embolism treatment, vascular recanalization or surgical operation treatment.
In use, the contents of steps 401 and 402 are combined:
obtaining an intra-nerve of a patientIndex of risk of stroke in the familyFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzWhether further examination is needed or not is judged, unnecessary examination is reduced, the effectiveness of examination is improved, unnecessary examination on low-risk patients is avoided, medical resources are more reasonably distributed, and more resources are used for other more needed patients.
Referring to fig. 2, the present invention provides an informationized management system for a neurological stroke patient, comprising:
the past risk assessment module is used for searching and acquiring the past basic medical history, past stroke medical history, family stroke medical history, age and sex of a patient in a medical system and acquiring basic disease coefficients after arrangementJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXbAnd further calculate to obtain the past estimated risk indexGp。
The clinical risk assessment module acquires clinical symptoms of patients and obtains the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp。
Comprehensive stroke risk assessment module for obtaining past assessment risk index of patientAnd clinical risk assessment indexCalculating to obtain stroke risk index of patient in neurologyFx。
The checking and judging module is used for acquiring a stroke risk index of a neurology department of a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzAnd determining whether further checking is required.
The above embodiments may be implemented in whole or in part by software, hardware, firmware, or any other combination. When implemented in software, the above-described embodiments may be implemented in whole or in part in the form of a computer program product. Those of ordinary skill in the art will appreciate that the various illustrative elements and algorithm steps described in connection with the embodiments disclosed herein may be implemented as electronic hardware, or combinations of computer software and electronic hardware. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the solution.
The units described as separate units may or may not be physically separate, and units shown as units may or may not be physical units, may be located in one place, or may be distributed on a plurality of network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of this embodiment.
The foregoing is merely specific embodiments of the present application, but the scope of the present application is not limited thereto, and any person skilled in the art can easily think about changes or substitutions within the technical scope of the present application, and the changes and substitutions are intended to be covered by the scope of the present application.
Claims (1)
1. An informatization management method for a neurological stroke patient is characterized by comprising the following steps of: the method comprises the following steps:
searching and obtaining the past basic medical history, past stroke medical history, family stroke medical history, age and sex of the patient in the medical system, and obtaining the basic disease coefficient of the patient after finishingJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc、Family coefficientJz、Age ofNlAnd sexXbAnd further calculate to obtain the past estimated risk indexGp；
Searching and acquiring the prior basic medical history of the patient in the medical system, wherein the basic medical history comprises hypertension, hyperglycemia, hyperlipidemia and diabetes, and recording the number of the basic diseases as basic disease coefficientsJcThe method comprises the steps of carrying out a first treatment on the surface of the Retrieval in a medical systemAcquiring family stroke history of patients, and recording the number of patients suffering from neurologic stroke as family coefficientJz；
Searching and obtaining past stroke medical history of patients in a medical system, wherein the past stroke medical history comprises neurologic stroke, type and time of each neurologic stroke, and obtaining the times of ischemic stroke after finishingQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTc；
Retrieving age of patient in medical systemNlAnd sexXbCombining basic disease coefficientsJc、Number of ischemic stroke eventsQcTime of stroke per ischemiaTqNumber of hemorrhagic strokesCxTime per strokeTcFamily coefficientJzAfter dimensionless treatment, calculating to obtain the past estimated risk indexGpCorresponding past evaluation risk indexGpThe calculation formula of (2) is as follows:
；
wherein, if the sex is male, the sex isXbMarking as 1, otherwise if the sex is female, the sexXbThe value is recorded as 0;
obtaining clinical symptoms of patients, and obtaining the number of clinical mild symptoms after finishingQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZgAnd further calculate to obtain clinical risk assessment indexLp；
Obtaining the number of clinical mild symptomsQgNumber of clinically moderate symptomsLgNumber of clinically severe symptomsZg，After linear normalization treatment, calculating to obtain clinical risk assessment indexLp：
；
Obtaining all past evaluation risk indexesAnd clinical risk assessment index->After dimensionless treatment, calculating to obtain the past estimated risk index ++>Weight of +.>And clinical risk assessment index->Weight of +.>Corresponding anamnesis risk index->Weight of +.>And clinical risk assessment index->Weight of +.>The calculation formula of (2) is as follows:
；
wherein,irepresenting each past evaluation risk indexAnd clinical risk assessment index->Is provided with a sequence number of (c) in the order,and (2) andnis a positive integer;
obtaining a past assessment risk index for a patientGpClinical risk assessment indexLpWeight k 1 And k 2 Calculating to obtain stroke risk index of patient in neurologyFx：
；
Obtaining a neurological stroke risk index for a patientFx，According to the stroke risk index of neurologyFxAnd risk thresholdYzJudging whether further examination is needed or not;
obtaining a neurological stroke risk index for all patientsAfter linear normalization processing, calculating to obtain a risk threshold valueYz：
；
When (when)Fx<YzWhen the current patient is fed back, the risk of stroke in the neurology is low, the symptoms are light, no further examination is performed, and monitoring is continuously kept so as to prevent abnormal situations;
when (when)Fx≥YzWhen the current patient is in high risk of stroke in neurology, the symptom is serious, and further examination is carried out to determine the specific focus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311805779.XA CN117457220B (en) | 2023-12-26 | 2023-12-26 | Informationized management method and system for neurological stroke patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311805779.XA CN117457220B (en) | 2023-12-26 | 2023-12-26 | Informationized management method and system for neurological stroke patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117457220A CN117457220A (en) | 2024-01-26 |
| CN117457220B true CN117457220B (en) | 2024-04-12 |
Family
ID=89582224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311805779.XA Active CN117457220B (en) | 2023-12-26 | 2023-12-26 | Informationized management method and system for neurological stroke patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117457220B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106066938A (en) * | 2016-06-03 | 2016-11-02 | 贡京京 | A kind of disease prevention and health control method and system |
| CN107895596A (en) * | 2016-12-19 | 2018-04-10 | 平安科技（深圳）有限公司 | Risk Forecast Method and system |
| CN110428901A (en) * | 2019-07-19 | 2019-11-08 | 中国医学科学院阜外医院 | Stroke onset Risk Forecast System and application |
| CN113040711A (en) * | 2021-03-03 | 2021-06-29 | 吾征智能技术(北京)有限公司 | Cerebral stroke attack risk prediction system, equipment and storage medium |
| CN113658704A (en) * | 2021-09-17 | 2021-11-16 | 平安国际智慧城市科技股份有限公司 | Diabetes risk prediction device, apparatus and storage medium |
| CN114334157A (en) * | 2022-01-19 | 2022-04-12 | 北京富通东方科技有限公司 | Cerebral apoplexy risk prediction method and device |
| CN116612891A (en) * | 2023-07-14 | 2023-08-18 | 营动智能技术(山东)有限公司 | Chronic patient data processing system |
-
2023
- 2023-12-26 CN CN202311805779.XA patent/CN117457220B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106066938A (en) * | 2016-06-03 | 2016-11-02 | 贡京京 | A kind of disease prevention and health control method and system |
| CN107895596A (en) * | 2016-12-19 | 2018-04-10 | 平安科技（深圳）有限公司 | Risk Forecast Method and system |
| CN110428901A (en) * | 2019-07-19 | 2019-11-08 | 中国医学科学院阜外医院 | Stroke onset Risk Forecast System and application |
| CN113040711A (en) * | 2021-03-03 | 2021-06-29 | 吾征智能技术(北京)有限公司 | Cerebral stroke attack risk prediction system, equipment and storage medium |
| CN113658704A (en) * | 2021-09-17 | 2021-11-16 | 平安国际智慧城市科技股份有限公司 | Diabetes risk prediction device, apparatus and storage medium |
| CN114334157A (en) * | 2022-01-19 | 2022-04-12 | 北京富通东方科技有限公司 | Cerebral apoplexy risk prediction method and device |
| CN116612891A (en) * | 2023-07-14 | 2023-08-18 | 营动智能技术(山东)有限公司 | Chronic patient data processing system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117457220A (en) | 2024-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lam et al. | Association of epileptiform abnormalities and seizures in Alzheimer disease | |
| Do et al. | Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list | |
| Fan et al. | Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990–2030 | |
| Shalev et al. | Gender differences in healthcare utilization and medical indicators among patients with diabetes | |
| Mathieu et al. | Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study | |
| Osuntokun et al. | Research protocol for measuring the prevalence of neurologic disorders in developing countries: results of a pilot study in Nigeria | |
| Romero et al. | Epidemiology of stroke: legacy of the Framingham Heart Study | |
| Bhattacharya et al. | Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial | |
| Pope et al. | Avoiding misdiagnosis in patients with neurological emergencies | |
| Ma et al. | Cognitive frailty and falls in Chinese elderly people: a population‐based longitudinal study | |
| Cosgriff et al. | External validation of the San Francisco Syncope Rule in the Australian context | |
| Agrawal et al. | Prevalence of and risk factors for eclampsia in pregnant women in India | |
| Zou et al. | Prevalence and associated socioeconomic factors of multimorbidity in 10 regions of China: an analysis of 0.5 million adults | |
| Struck et al. | The number of seizures needed in the EMU | |
| Wang et al. | C‐reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians | |
| Wright et al. | Serum PlGF compared with PAPP‐A in first trimester screening for preterm pre‐eclampsia: adjusting for the effect of aspirin treatment | |
| Pisciotta et al. | Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry | |
| Ackerman‐Banks et al. | Seizing the window of opportunity within 1 year postpartum: early cardiovascular screening | |
| Osman et al. | Bilateral independent periodic discharges are associated with electrographic seizures and poor outcome: a case-control study | |
| Sanders et al. | Clinical predictive value of the ABCD2 score for early risk of stroke in patients who have had transient ischaemic attack and who present to an Australian tertiary hospital | |
| CN117457220B (en) | Informationized management method and system for neurological stroke patients | |
| Mussi et al. | Metabolic syndrome and associated factors in quilombolas (inhabitants of black communities) from Bahia, Brazil | |
| Li et al. | Postoperative long-term independence among the elderly with meningiomas: function evolution, determinant identification, and prediction model development | |
| Chen et al. | Factors predicting the total medical costs associated with first-ever ischeamic stroke patients transferred to the rehabilitation ward. | |
| Zhang et al. | Derivation and validation of risk scores to predict cerebrovascular mortality among incident peritoneal dialysis patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |